M Atkins, D F Gray. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Drug Resistance, MicrobialHepatitis B virus/drug effectsHepatitis B virus/geneticsHepatitis B, Chronic/drug therapyHumansLamivudine/therapeutic usePolymorphism, Restriction Fragment LengthReverse Transcriptase Inhibitors/therapeutic use
Substances: See more » Reverse Transcriptase InhibitorsLamivudine
Year: 1998 PMID: 9537857 DOI: 10.1016/s0168-8278(98)80219-5
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083